Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study

The role of adjuvant chemoradiotherapy (CRT) in resectable pancreatic cancer is still debated. This randomized phase II intergroup study explores the feasibility and tolerability of a gemcitabine-based CRT regimen after R0 resection of pancreatic head cancer. Within 8 weeks after surgery, patients w...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of clinical oncology Ročník 28; číslo 29; s. 4450
Hlavní autoři:	Van Laethem, Jean-Luc, Hammel, Pascal, Mornex, Françoise, Azria, David, Van Tienhoven, Geertjan, Vergauwe, Philippe, Peeters, Marc, Polus, Marc, Praet, Michel, Mauer, Murielle, Collette, Laurence, Budach, Volker, Lutz, Manfred, Van Cutsem, Eric, Haustermans, Karin
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 10.10.2010
Témata:	Adult Aged Antimetabolites, Antineoplastic - adverse effects Antimetabolites, Antineoplastic - therapeutic use Chemotherapy, Adjuvant Combined Modality Therapy Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Deoxycytidine - therapeutic use Diarrhea - chemically induced Drug Administration Schedule Fatigue - chemically induced Feasibility Studies Female Humans Kaplan-Meier Estimate Male Middle Aged Nausea - chemically induced Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - radiotherapy Pancreatic Neoplasms - surgery Radiotherapy, Adjuvant Treatment Outcome
ISSN:	1527-7755, 1527-7755
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!